Additional priming mechanisms may include the activation of receptor-interacting protein 1 (RIPK1) or the NF-κB pathway by radiation therapy, both leading to the production and secretion of IL-1β in lung cancer cell lines [72]. This evidence concerns the gene RIPK1 and lung cancer.